Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
SAN DIEGO, Nov. 1 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today the pricing of its public offering of
11,000,000 shares of its common stock at a public offering price of $9.91 per
share. All of the shares are being offered by Arena. The underwriters have a
30-day option to purchase up to an additional 1,650,000 shares of common stock
to cover over-allotments, if any.
CIBC World Markets and UBS Investment Bank are acting as joint
book-running managers in this offering.
A registration statement relating to these securities has become effective
by rule of the Securities and Exchange Commission. Sales of shares pursuant to
this offering may be made only by means of the final prospectus supplement and
related prospectus, copies of which can be obtained from CIBC World Markets by
email at firstname.lastname@example.org, by phone at 212.667.7200, by fax at
212.667.6303, or by mail at CIBC World Markets, Attn: USE Prospectus
Department, 425 Lexington Avenue, 5th floor, New York, NY 10017, or from UBS
Investment Bank, Prospectus Department, 299 Park Avenue, 8th floor, New York,
NY 10171 or by phone at 888.827.7275. This press release shall not constitute
an offer to sell or the solicitation of an offer to buy, nor shall there be
any sale of, these securities in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to the registration or
qualification under the securities laws of any such jurisdiction.
Contacts: Jack Lief Mary Claire Duch
President and CEO WeissComm Partners
David Walsey 212.301.7228
Director, Corporate Communications
Arena Pharmaceuticals, Inc.
858.453.7200, ext. 1682
SOURCE Arena Pharmaceuticals, Inc.
/CONTACT: Jack Lief, President and CEO, or David Walsey, Director,
Corporate Communications, both of Arena Pharmaceuticals, Inc.,
+1-858-453-7200, ext. 1682; or media relations, Mary Claire Duch of WeissComm
Partners, +1-212-301-7228, for Arena Pharmaceuticals, Inc./
/Web site: http://www.arenapharm.com /
CO: Arena Pharmaceuticals, Inc.; CIBC World Markets; UBS Investment Bank
IN: HEA MTC
-- LATH212 --
2003 11/01/2007 21:39 EDT http://www.prnewswire.com
You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites.